Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy ; volume:15 ; number:1 ; day:15 ; month:10 ; year:2015 ; pages:1-11 ; date:12.2015
BMC cancer ; 15, Heft 1 (15.10.2015), 1-11, 12.2015
- Creator
-
Honma, Naoko
- Contributor
-
Horii, Rie
Itō, Yoshinori
Saji, Shigehira
Younes, Mamoun
Iwase, Takuji
Akiyama, Futoshi
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1686-y
- URN
-
urn:nbn:de:1111-2016110621864
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Honma, Naoko
- Horii, Rie
- Itō, Yoshinori
- Saji, Shigehira
- Younes, Mamoun
- Iwase, Takuji
- Akiyama, Futoshi
- SpringerLink (Online service)
Other Objects (12)
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Endocrine disrupting chemicals : interaction with estrogen receptors an in vitro assessment of endocrine activity potential
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Modelling the interaction of steroid receptors with endocrine disrupting chemicals
Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors
Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Nuclear receptors: variants and their role in neuro-endocrine immune regulations
b-cl
b-cl
b-cl
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Endocrine disrupting chemicals : interaction with estrogen receptors an in vitro assessment of endocrine activity potential
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Modelling the interaction of steroid receptors with endocrine disrupting chemicals
Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors
Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Nuclear receptors: variants and their role in neuro-endocrine immune regulations
b-cl
b-cl
b-cl
Status of adjuvant endocrine therapy for breast cancer
Understanding adjuvant endocrine therapy persistence in breast Cancer survivors
Endocrine disrupting chemicals : interaction with estrogen receptors an in vitro assessment of endocrine activity potential
Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
Modelling the interaction of steroid receptors with endocrine disrupting chemicals
Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors
Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors
Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
Nuclear receptors: variants and their role in neuro-endocrine immune regulations
b-cl
b-cl